MTOR and cancer: In cancer cell lines, AMPK activators, such as metformin, can significantly inhibit cell growth by induction of cell cycle arrest through AMPK activation, and this effect may be associated with suppression of anabolism through inhibition of mTOR by phosphorylating tuberous sclerosis 2 (TSC2) [99,100,101].